KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Treasury Shares (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Treasury Shares for 5 consecutive years, with $77.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares rose 218.25% year-over-year to $77.0 million, compared with a TTM value of $77.0 million through Sep 2025, up 218.25%, and an annual FY2024 reading of $31.0 million, up 143.47% over the prior year.
  • Treasury Shares was $5.1 million for Q4 2025 at Clover Health Investments, down from $30.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $30.3 million in Q3 2025 and bottomed at -$1.7 million in Q3 2023.
  • Average Treasury Shares over 5 years is $9.5 million, with a median of $5.3 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 4327.89% in 2022, then skyrocketed 55.95% in 2023.
  • Year by year, Treasury Shares stood at $147000.0 in 2021, then surged by 4327.89% to $6.5 million in 2022, then soared by 95.56% to $12.7 million in 2023, then surged by 143.47% to $31.0 million in 2024, then soared by 148.43% to $77.0 million in 2025.
  • Business Quant data shows Treasury Shares for CLOV at $77.0 million in Q3 2025, $71.4 million in Q2 2025, and $62.9 million in Q1 2025.